Insulet (PODD) Stock Insights
PODD$148.93-0.90 -0.60%
$10.33B
Market Cap
27.85
P/E
22.89
Forward P/E
70
Score
Insulet (PODD) Stock Insights
PODD price $148.93 -0.90 -0.60%
- Ticker
- PODD
- Price
- $148.93
- Change
- -0.90 -0.60%
- Market cap ?
- $10.33B
- P/E ?
- 27.85
- Forward P/E ?
- 22.89
- Dividend yield ?
- 0.00%
- Beta ?
- 1.10
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 70
- Value
- 62
- Quality
- 67
- Growth
- 81
Stocklytics score rationale: value 62, quality 67, growth 81.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 366989000 | 463768000 | 563823000 | 738200000 | 904400000 | 1098800000 | 1305300000 | 1697100000 | 2071600000 | 2708100000 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values…
Fair value
PODD fair value $166.79. Price $148.93. Price is 11% below fair value.
Above fair value, but less expensive than usual. A smaller premium than on 88% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 251.07M. Growth 11.74%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.36% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 69.35M. Net debt 334.70M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 1.59 | — | 832.63M |
| 2026-08-05 | 1.66 | 1.47 | 801.70M | 787.39M |
| 2026-05-06 | 1.42 | 1.19 | 761.70M | 729.89M |
| 2026-02-18 | 1.55 | 1.47 | 783.80M | 768.97M |
| 2025-11-06 | 1.24 | 1.14 | 706.30M | 678.41M |
| 2025-08-07 | 1.17 | 0.92 | 649.10M | 614.20M |
| 2025-05-08 | 1.02 | 0.79 | 569.00M | 543.29M |
| 2025-02-20 | 1.15 | 1.00 | 597.50M | 582.54M |
| 2024-11-07 | 0.90 | 0.76 | 543.90M | 519.51M |
| 2024-08-08 | 0.55 | 0.56 | 488.50M | 488.00M |
| 2024-05-09 | 0.73 | 0.39 | 441.70M | 424.05M |
| 2024-02-22 | 1.40 | 0.66 | 509.80M | 461.05M |
| 2023-11-02 | 0.71 | 0.40 | 432.70M | 414.38M |
| 2023-08-08 | 0.38 | 0.26 | 396.50M | 384.95M |
| 2023-05-04 | 0.23 | 0.11 | 358.10M | 330.91M |
| 2023-02-23 | 0.25 | 0.24 | 369.70M | 332.45M |
| 2022-11-03 | 0.45 | 0.17 | 340.80M | 312.11M |
| 2022-08-04 | -0.50 | 0.21 | 299.40M | 291.45M |
| 2022-05-05 | 0.40 | 0.23 | 295.40M | 288.02M |
| 2022-02-23 | 0.42 | 0.32 | 307.70M | 299.33M |
| 2021-11-04 | 0.18 | 0.24 | 275.60M | 272.82M |
| 2021-08-05 | 0.10 | 0.12 | 263.20M | 259.08M |
| 2021-05-06 | 0.01 | 0.07 | 252.30M | 246.22M |
| 2021-02-23 | -0.26 | -0.06 | 246.10M | 996.71M |
| 2020-11-04 | 0.17 | 0.08 | 234.00M | 162.89M |
| 2020-08-06 | 0.22 | 0.00 | 226.30M | — |
| 2020-05-07 | -0.03 | -0.00 | 198.00M | — |
| 2020-02-25 | 0.08 | 0.11 | 209.40M | 287.92M |
| 2019-11-05 | 0.09 | 0.29 | 192.12M | 576.34M |
| 2019-08-05 | 0.02 | 0.02 | 177.14M | 265.70M |
| 2019-05-02 | 0.07 | 0.01 | 159.56M | 22.79M |
| 2019-02-25 | 0.16 | 0.07 | 164.91M | 116.61M |
| 2018-11-01 | 0.03 | 0.00 | 151.08M | — |
| 2018-08-02 | -0.03 | -0.13 | 124.26M | 538.47M |
| 2018-05-03 | -0.11 | -0.19 | 123.58M | 213.45M |
| 2018-02-21 | -0.12 | -0.08 | 130.52M | 87.02M |
| 2017-11-02 | -0.04 | -0.10 | 121.78M | 304.44M |
| 2017-08-03 | -0.13 | -0.13 | 109.76M | 109.76M |
| 2017-05-08 | -0.17 | -0.16 | 101.71M | 89.75M |
| 2017-02-27 | -0.16 | -0.05 | 103.58M | 32.37M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Pease Flavia | Sell | 1.88K | $130.79 | 246.15K |
| 2026-09-30 | MAZELSKY JONATHAN JAY | Buy | 141 | $130.47 | 18.40K |
| 2026-09-30 | Huffines Robert Luther | Buy | 178 | $130.47 | 23.22K |
| 2026-08-21 | McEvoy Ashley | Buy | 1.10K | $147.47 | 162.22K |
| 2026-08-01 | Davis Lisa Blair | Sell | 244 | $165.35 | 40.35K |
| 2026-07-01 | MAZELSKY JONATHAN JAY | Buy | 1.35K | — | — |
| 2026-07-01 | MAZELSKY JONATHAN JAY | Other | 0 | — | — |
| 2026-06-30 | Huffines Robert Luther | Buy | 151 | $152.25 | 22.99K |
| 2026-06-30 | Huffines Robert Luther | Buy | 144 | $159.79 | 23.01K |
| 2026-06-03 | STONESIFER TIMOTHY C. | Buy | 2.79K | $143.51 | 400.39K |
| 2026-06-03 | BORIO LUCIANA | Sell | 418 | $143.27 | 59.89K |
| 2026-05-20 | WEATHERMAN ELIZABETH H | Buy | 1.66K | — | — |
| 2026-05-20 | STONESIFER TIMOTHY C. | Buy | 1.66K | — | — |
| 2026-05-20 | Scannell Timothy J | Buy | 1.66K | — | — |
| 2026-05-20 | MINOGUE MICHAEL R | Buy | 1.66K | — | — |
| 2026-05-20 | Huffines Robert Luther | Buy | 1.66K | — | — |
| 2026-05-20 | Hopfield Jessica | Buy | 1.66K | — | — |
| 2026-05-20 | Frederick Wayne A.I. | Buy | 1.66K | — | — |
| 2026-05-20 | BORIO LUCIANA | Buy | 1.66K | — | — |
| 2026-05-13 | McEvoy Ashley | Sell | 1.41K | $148.84 | 210.01K |
| 2026-04-01 | Panos Michael | Buy | 7.25K | $207.04 | 1.50M |
| 2026-04-01 | Panos Michael | Buy | 2.78K | — | — |
| 2026-03-31 | Huffines Robert Luther | Buy | 111 | $209.84 | 23.29K |
| 2026-03-30 | Panos Michael | Other | 0 | — | — |
| 2026-02-27 | Singh Prem | Sell | 207 | $246.61 | 51.05K |
| 2026-02-27 | Singh Prem | Sell | 62 | $246.61 | 15.29K |
| 2026-02-27 | Cousin Laetitia | Sell | 200 | $246.61 | 49.32K |
| 2026-02-27 | Cousin Laetitia | Sell | 53 | $246.61 | 13.07K |
| 2026-02-27 | Budden Lauren | Sell | 119 | $246.61 | 29.35K |
| 2026-02-27 | Budden Lauren | Sell | 99 | $246.61 | 24.41K |
| 2026-02-27 | Kapples John W. | Sell | 411 | $246.61 | 101.36K |
| 2026-02-27 | Kapples John W. | Sell | 194 | $246.61 | 47.84K |
| 2026-02-27 | Benjamin Eric | Sell | 644 | $246.61 | 158.82K |
| 2026-02-27 | Benjamin Eric | Sell | 268 | $246.61 | 66.09K |
| 2026-02-25 | Singh Prem | Sell | 138 | $248.12 | 34.24K |
| 2026-02-25 | Cousin Laetitia | Sell | 111 | $248.12 | 27.54K |
| 2026-02-25 | Budden Lauren | Sell | 55 | $248.12 | 13.65K |
| 2026-02-25 | Kapples John W. | Sell | 263 | $248.12 | 65.26K |
| 2026-02-25 | Benjamin Eric | Sell | 395 | $248.12 | 98.01K |
| 2026-02-25 | MINOGUE MICHAEL R | Buy | 2.03K | $246.23 | 499.85K |
| 2026-02-24 | Singh Prem | Buy | 2.14K | — | — |
| 2026-02-24 | Singh Prem | Buy | 5.57K | $245.25 | 1.37M |
| 2026-02-24 | Cousin Laetitia | Buy | 1.04K | — | — |
| 2026-02-24 | Cousin Laetitia | Buy | 2.72K | $245.25 | 666.59K |
| 2026-02-24 | Budden Lauren | Buy | 611 | — | — |
| 2026-02-24 | Budden Lauren | Buy | 1.59K | $245.25 | 390.19K |
| 2026-02-24 | Kapples John W. | Buy | 1.89K | — | — |
| 2026-02-24 | Kapples John W. | Buy | 4.91K | $245.25 | 1.20M |
| 2026-02-24 | Benjamin Eric | Buy | 3.82K | — | — |
| 2026-02-24 | Benjamin Eric | Buy | 9.95K | $245.25 | 2.44M |
| 2026-02-24 | Davis Lisa Blair | Buy | 5.57K | $245.25 | 1.37M |
| 2026-02-24 | Davis Lisa Blair | Buy | 2.14K | — | — |
| 2026-02-24 | Pease Flavia | Buy | 3.82K | — | — |
| 2026-02-24 | Pease Flavia | Buy | 9.95K | $245.25 | 2.44M |
| 2026-02-24 | McEvoy Ashley | Buy | 26.14K | $245.25 | 6.41M |
| 2026-02-24 | McEvoy Ashley | Buy | 10.05K | — | — |
| 2026-02-20 | McEvoy Ashley | Buy | 4.30K | $239.35 | 1.03M |
| 2026-02-12 | Singh Prem | Buy | 2.53K | — | — |
| 2026-02-12 | Singh Prem | Sell | 861 | $240.82 | 207.35K |
| 2026-02-12 | Kapples John W. | Buy | 5.25K | — | — |
| 2026-02-12 | Kapples John W. | Sell | 1.93K | $240.82 | 464.54K |
| 2026-02-12 | Cousin Laetitia | Buy | 1.81K | — | — |
| 2026-02-12 | Cousin Laetitia | Sell | 564 | $240.82 | 135.82K |
| 2026-02-12 | Budden Lauren | Buy | 1.81K | — | — |
| 2026-02-12 | Budden Lauren | Sell | 622 | $240.82 | 149.79K |
| 2026-02-12 | Benjamin Eric | Buy | 7.24K | — | — |
| 2026-02-12 | Benjamin Eric | Sell | 2.89K | $240.82 | 695.25K |
| 2026-01-02 | Cousin Laetitia | Sell | 140 | $282.92 | 39.61K |
| 2025-12-31 | Huffines Robert Luther | Buy | 51 | $284.24 | 14.44K |
| 2025-12-15 | Frederick Wayne A.I. | Sell | 1.85K | $293.09 | 542.51K |
| 2025-12-05 | STONESIFER TIMOTHY C. | Buy | 962 | $311.73 | 299.88K |
| 2025-10-31 | Huffines Robert Luther | Buy | 477 | — | — |
| 2025-10-31 | Huffines Robert Luther | Other | 0 | — | — |
| 2025-10-01 | Pease Flavia | Buy | 11.71K | — | — |
| 2025-10-01 | Pease Flavia | Buy | 1.64K | $305.98 | 502.11K |
| 2025-09-08 | Singh Prem | Sell | 687 | $347.49 | 238.73K |
| 2025-09-08 | Cousin Laetitia | Buy | 256 | $166.60 | 42.65K |
| 2025-09-08 | Cousin Laetitia | Buy | 541 | $276.36 | 149.51K |
| 2025-09-08 | Cousin Laetitia | Sell | 797 | $348.81 | 278.00K |
| 2025-09-08 | Cousin Laetitia | Sell | 256 | $166.62 | 42.65K |
| 2025-09-08 | Cousin Laetitia | Sell | 541 | $276.36 | 149.51K |
| 2025-08-21 | Benjamin Eric | Sell | 4.26K | $332.23 | 1.42M |
| 2025-08-21 | MINOGUE MICHAEL R | Buy | 1.38K | — | — |
| 2025-08-21 | MINOGUE MICHAEL R | Sell | 1.38K | — | — |
| 2025-08-19 | MINOGUE MICHAEL R | Buy | 9.46K | — | — |
| 2025-08-19 | MINOGUE MICHAEL R | Buy | 9.46K | — | — |
| 2025-08-19 | MINOGUE MICHAEL R | Sell | 9.46K | — | — |
| 2025-08-19 | MINOGUE MICHAEL R | Sell | 9.46K | — | — |
| 2025-08-07 | Singh Prem | Buy | 758 | $276.36 | 209.48K |
| 2025-08-07 | Singh Prem | Buy | 585 | $264.69 | 154.84K |
| 2025-08-07 | Singh Prem | Sell | 1.34K | $320.00 | 429.76K |
| 2025-08-07 | Singh Prem | Sell | 758 | $276.36 | 209.48K |
| 2025-08-07 | Singh Prem | Sell | 585 | $264.69 | 154.84K |
| 2025-08-01 | Davis Lisa Blair | Buy | 2.48K | — | — |
| 2025-08-01 | Davis Lisa Blair | Buy | 1.87K | $284.91 | 532.50K |
| 2025-07-08 | Davis Lisa Blair | Other | 0 | — | — |
| 2025-06-13 | Singh Prem | Buy | 1.26K | $166.62 | 209.44K |
| 2025-06-13 | Singh Prem | Sell | 2.33K | $300.05 | 698.22K |
| 2025-06-13 | Singh Prem | Sell | 1.26K | $166.62 | 209.44K |
| 2025-06-13 | Manea Dan | Sell | 1.30K | $300.05 | 390.06K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 753, holders -49 vs prior quarter. Ownership 103.37%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 6.69M | 314.25K | +4.93% | 1.02B |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.53M | -53.94K | -1.18% | 688.98M |
| STATE STREET CORP | 3.20M | 155.10K | +5.10% | 486.83M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.08M | -374.06K | -10.84% | 468.31M |
| AQR CAPITAL MANAGEMENT LLC | 2.46M | 856.41K | +53.57% | 373.79M |
| BAILLIE GIFFORD & CO | 2.04M | 12.82K | +0.63% | 310.94M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.00M | -21.84K | -1.08% | 303.97M |
| TWO SIGMA INVESTMENTS, LP | 1.90M | 1.14M | +149.72% | 289.84M |
| INVESCO LTD. | 1.69M | 598.11K | +54.55% | 258.01M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.51M | -303.58K | -16.72% | 230.23M |
| MORGAN STANLEY | 1.48M | 333.12K | +29.07% | 225.19M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.47M | 241.14K | +19.61% | 223.97M |
| CLEARBRIDGE INVESTMENTS, LLC | 1.32M | -1.65K | -0.12% | 200.88M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.05M | 486.50K | +86.49% | 159.71M |
| NORGES BANK | 1.05M | 1.05M | New | 159.56M |
| JUPITER ASSET MANAGEMENT LTD | 1.03M | 316.79K | +44.62% | 156.31M |
| FMR LLC | 964.30K | -3.01M | -75.74% | 146.81M |
| MILLENNIUM MANAGEMENT LLC | 865.39K | 566.79K | +189.82% | 131.76M |
| FIL LTD | 840.03K | -171.98K | -16.99% | 127.89M |
| GOLDMAN SACHS GROUP INC | 818.26K | -45.65K | -5.28% | 124.58M |
| CITADEL ADVISORS LLC | 796.75K | 643.31K | +419.26% | 121.30M |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 773.36K | -21.99K | -2.76% | 117.74M |
| FEDERATED HERMES, INC. | 702.19K | -11.70K | -1.64% | 106.91M |
| VESTAL POINT CAPITAL, LP | 670.00K | 670.00K | New | 102.01M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 663.97K | 22.29K | +3.47% | 101.09M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2016 | Drug Delivery: 65315000.0, International Omnipod: 301674000.0 |
| FY2017 | Drug Delivery: 72218000.0, International Omnipod: 391550000.0 |
| FY2019 | Drug Delivery: 64700000.0, International Omnipod: 673500000.0 |
| FY2020 | Drug Delivery: 69500000.0, International Omnipod: 834900000.0 |
| FY2021 | Drug Delivery: 87400000.0, International Omnipod: 1011400000.0 |
| FY2022 | Drug Delivery: 57500000.0, International Omnipod: 1247800000.0 |
| FY2023 | Drug Delivery: 36000000.0, International Omnipod: 1661100000.0 |
| FY2024 | Drug Delivery: 38900000.0, International Omnipod: 2032700000.0 |
| FY2025 | Drug Delivery: 34100000.0, International Omnipod: 2674100000.0 |
| Period | Value |
|---|---|
| FY2016 | Non-US: 71889000.0, UNITED STATES: 295100000.0 |
| FY2017 | Non-US: 119953000.0, UNITED STATES: 343815000.0 |
| FY2018 | Non-US: 172020000.0, UNITED STATES: 391803000.0 |
| FY2019 | Non-US: 253100000.0, UNITED STATES: 485100000.0 |
| FY2020 | Non-US: 308000000.0, UNITED STATES: 596400000.0 |
| FY2021 | Non-US: 359900000.0, UNITED STATES: 738900000.0 |
| FY2022 | Non-US: 363000000.0, UNITED STATES: 942300000.0 |
| FY2023 | Non-US: 410100000.0, UNITED STATES: 1287000000.0 |
| FY2024 | Non-US: 523400000.0, UNITED STATES: 1548200000.0 |
| FY2025 | Non-US: 754300000.0, UNITED STATES: 1953900000.0 |
Insights · Dividends · Forecast · Financials · Learn